Literature DB >> 17241609

Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers.

Jeffrey R Whiteaker1, Lei Zhao, Heidi Y Zhang, Li-Chia Feng, Brian D Piening, Leigh Anderson, Amanda G Paulovich.   

Abstract

A major bottleneck for validation of new clinical diagnostics is the development of highly sensitive and specific assays for quantifying proteins. We previously described a method, stable isotope standards with capture by antipeptide antibodies, wherein a specific tryptic peptide is selected as a stoichiometric representative of the protein from which it is cleaved, is enriched from biological samples using immobilized antibodies, and is quantitated using mass spectrometry against a spiked internal standard to yield a measure of protein concentration. In this study, we optimized a magnetic-bead-based platform amenable to high-throughput peptide capture and demonstrated that antibody capture followed by mass spectrometry can achieve ion signal enhancements on the order of 10(3), with precision (CVs <10%) and accuracy (relative error approximately 20%) sufficient for quantifying biomarkers in the physiologically relevant ng/mL range. These methods are generally applicable to any protein or biological fluid of interest and hold great potential for providing a desperately needed bridging technology between biomarker discovery and clinical application.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17241609      PMCID: PMC1852426          DOI: 10.1016/j.ab.2006.12.023

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  34 in total

1.  alpha 1-Antichymotrypsin is the human plasma inhibitor of macrophage ectoenzymes that cleave pro-macrophage stimulating protein.

Authors:  A Skeel; E J Leonard
Journal:  J Biol Chem       Date:  2001-03-23       Impact factor: 5.157

Review 2.  Target discovery.

Authors:  Mark A Lindsay
Journal:  Nat Rev Drug Discov       Date:  2003-10       Impact factor: 84.694

3.  High throughput proteome screening for biomarker detection.

Authors:  Sheng Pan; Hui Zhang; John Rush; Jimmy Eng; Ning Zhang; Dale Patterson; Michael J Comb; Ruedi Aebersold
Journal:  Mol Cell Proteomics       Date:  2005-01-05       Impact factor: 5.911

4.  18O-labeling quantitative proteomics using an ion trap mass spectrometer.

Authors:  Jun Sakai; Shinichi Kojima; Kazunori Yanagi; Masaharu Kanaoka
Journal:  Proteomics       Date:  2005-01       Impact factor: 3.984

Review 5.  Scoring proteomes with proteotypic peptide probes.

Authors:  Bernhard Kuster; Markus Schirle; Parag Mallick; Ruedi Aebersold
Journal:  Nat Rev Mol Cell Biol       Date:  2005-07       Impact factor: 94.444

6.  Online immunoaffinity liquid chromatography/tandem mass spectrometry determination of a type II collagen peptide biomarker in rat urine: Investigation of the impact of collision-induced dissociation fluctuation on peptide quantitation.

Authors:  Michael Berna; Chris Schmalz; Kevin Duffin; Peter Mitchell; Mark Chambers; Brad Ackermann
Journal:  Anal Biochem       Date:  2006-06-09       Impact factor: 3.365

Review 7.  Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

Authors:  P L Fitzgibbons; D L Page; D Weaver; A D Thor; D C Allred; G M Clark; S G Ruby; F O'Malley; J F Simpson; J L Connolly; D F Hayes; S B Edge; A Lichter; S J Schnitt
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

Review 8.  Trastuzumab/chemotherapy combinations in metastatic breast cancer.

Authors:  Jennifer A Ligibel; Eric P Winer
Journal:  Semin Oncol       Date:  2002-06       Impact factor: 4.929

Review 9.  Smart drugs: tyrosine kinase inhibitors in cancer therapy.

Authors:  Laura K Shawver; Dennis Slamon; Axel Ullrich
Journal:  Cancer Cell       Date:  2002-03       Impact factor: 31.743

10.  Magnetic techniques for the isolation and purification of proteins and peptides.

Authors:  Ivo Safarik; Mirka Safarikova
Journal:  Biomagn Res Technol       Date:  2004-11-26
View more
  82 in total

1.  The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline.

Authors:  Amanda G Paulovich; Jeffrey R Whiteaker; Andrew N Hoofnagle; Pei Wang
Journal:  Proteomics Clin Appl       Date:  2008-10-01       Impact factor: 3.494

2.  Interlaboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma.

Authors:  Eric Kuhn; Jeffrey R Whiteaker; D R Mani; Angela M Jackson; Lei Zhao; Matthew E Pope; Derek Smith; Keith D Rivera; N Leigh Anderson; Steven J Skates; Terry W Pearson; Amanda G Paulovich; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2011-12-22       Impact factor: 5.911

3.  Resistive pulse sensing of magnetic beads and supraparticle structures using tunable pores.

Authors:  Geoff R Willmott; Mark Platt; Gil U Lee
Journal:  Biomicrofluidics       Date:  2012-01-12       Impact factor: 2.800

4.  Targeting peptide termini, a novel immunoaffinity approach to reduce complexity in mass spectrometric protein identification.

Authors:  Sibylle Hoeppe; Thomas D Schreiber; Hannes Planatscher; Andreas Zell; Markus F Templin; Dieter Stoll; Thomas O Joos; Oliver Poetz
Journal:  Mol Cell Proteomics       Date:  2010-10-20       Impact factor: 5.911

Review 5.  Replacing immunoassays with tryptic digestion-peptide immunoaffinity enrichment and LC-MS/MS.

Authors:  Jessica O Becker; Andrew N Hoofnagle
Journal:  Bioanalysis       Date:  2012-02       Impact factor: 2.681

Review 6.  Reverse phase protein microarrays advance to use in clinical trials.

Authors:  Claudius Mueller; Lance A Liotta; Virginia Espina
Journal:  Mol Oncol       Date:  2010-10-16       Impact factor: 6.603

7.  Deep-Dive Targeted Quantification for Ultrasensitive Analysis of Proteins in Nondepleted Human Blood Plasma/Serum and Tissues.

Authors:  Song Nie; Tujin Shi; Thomas L Fillmore; Athena A Schepmoes; Heather Brewer; Yuqian Gao; Ehwang Song; Hui Wang; Karin D Rodland; Wei-Jun Qian; Richard D Smith; Tao Liu
Journal:  Anal Chem       Date:  2017-08-11       Impact factor: 6.986

8.  Protein quantitation through targeted mass spectrometry: the way out of biomarker purgatory?

Authors:  Steven A Carr; Leigh Anderson
Journal:  Clin Chem       Date:  2008-11       Impact factor: 8.327

Review 9.  Clinical potential of mass spectrometry-based proteogenomics.

Authors:  Bing Zhang; Jeffrey R Whiteaker; Andrew N Hoofnagle; Geoffrey S Baird; Karin D Rodland; Amanda G Paulovich
Journal:  Nat Rev Clin Oncol       Date:  2019-04       Impact factor: 66.675

10.  Automated screening of monoclonal antibodies for SISCAPA assays using a magnetic bead processor and liquid chromatography-selected reaction monitoring-mass spectrometry.

Authors:  Regine M Schoenherr; Lei Zhao; Jeffrey R Whiteaker; Li-Chia Feng; Li Li; Lina Liu; Xiuwen Liu; Amanda G Paulovich
Journal:  J Immunol Methods       Date:  2009-12-01       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.